Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by the t(9;22)(q34;q11) chromosomal translocation, which results in the constitutively active BCR::ABL1 fusion oncogene [1]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.